Analytical Hub Disclaimer
"This information is intended to serve as a resource for informational purposes only and not as an USP-NF compendial documentary standard. USP shall not be responsible to verify the accuracy, completeness, timeliness, quality, and correctness of the information developed and/or posted by its members. This document is on an “as-is”, “as available” basis and USP expressly disclaims all warranties, including the warranties of merchantability, fitness for a particular purpose, and non-infringement. This document does not reflect USP or USP’s Expert Body opinions. Parties relying on the information in this document bear independent responsibility for awareness of, and compliance with, any applicable federal, state, or local laws and requirements.”
“By participating in discussions and posting content within the Analytical Hub, you confirm your agreement to the original Terms of Service of the Nitrosamines Exchange Community. We remind all members to respect intellectual property rights when sharing information, data, or resources. This includes but is not limited to: 1) Avoiding unauthorized distribution. 2) Crediting original sources. 3) Protecting proprietary information.”
N-Nitroso-Propranolol in Propranolol Capsules
See attached for our validation report and associated test method. This test method is validated for the analysis of API and capsule formulations using a Sciex X500R QToF.
Validation Report for N-Nitroso-Propranolol in Propranolol .pdf (806.4 KB)